Trial Information

Summary: HORIZON Therapeutics protocol HZ-CA-301: A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment

Horizon Therapeutics is conducting a clinical research study evaluating an investigational medication that combines a medication with proven pain relief (NSAID) with proven stomach protection-into one singe pill. Published studies show that NSAID pain relievers taken alone can cause stomach ulcers in up to 1 in 4 people who take them for chronic pain relief.

Compensation for time and travel will be provided.

The study requires that you must be:

• 40 years or older
• suffering from chronic pain such as: osteoarthritis, rheumatoid arthritis, lower back or other joint-related pain
• interested in participating in a clinical study that closely monitors your health

Compensation for time and travel will be provided.

Study participation includes, at no cost to you:

• study visits with experienced medical professionals
• study drug for up to 7 months
• study procedures and evaluations

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:46 AM